| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pharmacology [G. R., A. L., A. C. S.], Howard Hughes Medical Institute, Section of Immunobiology [R. A. F.] and Cancer Center, Yale University School of Medicine, New Haven, Connecticut 06520
The MRP (multidrug resistance protein) gene, a member of the ubiquitous superfamily of ATP-binding cassette transporters, is associated with the multidrug resistance of mammalian cells to natural product anticancer agents. We have previously shown that abrogation of MRP expression by gene targeting leads to hypersensitivity to several drugs. In two independently produced MRP double knockout clones, the baseline export of glutathione (GSH) was one-half that of wild-type embryonic stem (ES) cells. The export of GSH from wild-type ES cells, but not from the MRP double knockout clones, increased in the presence of etoposide (VP-16) and sodium arsenite, accompanied by equivalent decreases in intracellular levels of GSH. In the two MRP double knockout clones, the intracellular steady-state concentration of etoposide was twofold greater than that in wild-type cells. Depletion of intracellular GSH by D,L-buthionine sulfoximine increased the intracellular accumulation of radiolabeled etoposide in parental ES cells up to the level present in the two MRP knockout clones but did not change etoposide levels in the MRP knockout clones. These observations provide evidence that: (a) MRP exports GSH physiologically, presumably in association with an endogenous compound(s); (b) baseline MRP expression protects cells from the toxic effects of xenobiotics by effluxing the xenobiotics and GSH from the intracellular compartment into the extracellular medium by a co-transport mechanism; and (c) disruption of the gene encoding MRP abrogates the cotransport of xenobiotics and GSH.
1 Supported in part by USPHS Grants CA-66739 and CA-16359 from the National Cancer Institute.
2 To whom requests for reprints should be addressed, at the Department of Pharmacology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520.
Received 8/21/97. Accepted 10/17/97.
This article has been cited by other articles:
![]() |
Y. Lai, L. Xing, G. I. Poda, and Y. Hu Structure-Activity Relationships for Interaction with Multidrug Resistance Protein 2 (ABCC2/MRP2): The Role of Torsion Angle for a Series of Biphenyl-Substituted Heterocycles Drug Metab. Dispos., June 1, 2007; 35(6): 937 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Leung, A. Pang, W.-H. Yuen, Y.-L. Kwong, and E. W. C. Tse Relationship of expression of aquaglyceroporin 9 with arsenic uptake and sensitivity in leukemia cells Blood, January 15, 2007; 109(2): 740 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Deeley, C. Westlake, and S. P. C. Cole Transmembrane Transport of Endo- and Xenobiotics by Mammalian ATP-Binding Cassette Multidrug Resistance Proteins. Physiol Rev, July 1, 2006; 86(3): 849 - 899. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dallas, D. S. Miller, and R. Bendayan Multidrug resistance-associated proteins: expression and function in the central nervous system. Pharmacol. Rev., June 1, 2006; 58(2): 140 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rothnie, R. Callaghan, R. G. Deeley, and S. P. C. Cole Role of GSH in Estrone Sulfate Binding and Translocation by the Multidrug Resistance Protein 1 (MRP1/ABCC1) J. Biol. Chem., May 19, 2006; 281(20): 13906 - 13914. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-W. Zhang, K. Nunoya, M. Vasa, H.-M. Gu, S. P. C. Cole, and R. G. Deeley MUTATIONAL ANALYSIS OF POLAR AMINO ACID RESIDUES WITHIN PREDICTED TRANSMEMBRANE HELICES 10 AND 16 OF MULTIDRUG RESISTANCE PROTEIN 1 (ABCC1): EFFECT ON SUBSTRATE SPECIFICITY Drug Metab. Dispos., April 1, 2006; 34(4): 539 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Morrow, C. Peklak-Scott, B. Bishwokarma, T. E. Kute, P. K. Smitherman, and A. J. Townsend Multidrug Resistance Protein 1 (MRP1, ABCC1) Mediates Resistance to Mitoxantrone via Glutathione-Dependent Drug Efflux Mol. Pharmacol., April 1, 2006; 69(4): 1499 - 1505. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. SZWERGOLD, S. K. HOWELL, and P. J. BEISSWENGER Transglycation--A Potential New Mechanism for Deglycation of Schiff's Bases Ann. N.Y. Acad. Sci., June 1, 2005; 1043(1): 845 - 864. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Benlloch, A. Ortega, P. Ferrer, R. Segarra, E. Obrador, M. Asensi, J. Carretero, and J. M. Estrela Acceleration of Glutathione Efflux and Inhibition of {gamma}-Glutamyltranspeptidase Sensitize Metastatic B16 Melanoma Cells to Endothelium-induced Cytotoxicity J. Biol. Chem., February 25, 2005; 280(8): 6950 - 6959. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Depeille, P. Cuq, S. Mary, I. Passagne, A. Evrard, D. Cupissol, and L. Vian Glutathione S-Transferase M1 and Multidrug Resistance Protein 1 Act in Synergy to Protect Melanoma Cells from Vincristine Effects Mol. Pharmacol., April 1, 2004; 65(4): 897 - 905. [Abstract] [Full Text] |
||||
![]() |
D.-W. Zhang, H.-M. Gu, D. Situ, A. Haimeur, S. P. C. Cole, and R. G. Deeley Functional Importance of Polar and Charged Amino Acid Residues in Transmembrane Helix 14 of Multidrug Resistance Protein 1 (MRP1/ABCC1): IDENTIFICATION OF AN ASPARTATE RESIDUE CRITICAL FOR CONVERSION FROM A HIGH TO LOW AFFINITY SUBSTRATE BINDING STATE J. Biol. Chem., November 14, 2003; 278(46): 46052 - 46063. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nunoya, C. E. Grant, D. Zhang, S. P. C. Cole, and R. G. Deeley MOLECULAR CLONING AND PHARMACOLOGICAL CHARACTERIZATION OF RAT MULTIDRUG RESISTANCE PROTEIN 1 (MRP1) Drug Metab. Dispos., August 1, 2003; 31(8): 1016 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Lockhart, R. G. Tirona, and R. B. Kim Pharmacogenetics of ATP-binding Cassette Transporters in Cancer and Chemotherapy Mol. Cancer Ther., July 1, 2003; 2(7): 685 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Konno, T. Ebihara, K. Hisaeda, T. Uchiumi, T. Nakamura, T. Shirakusa, M. Kuwano, and M. Wada Identification of Domains Participating in the Substrate Specificity and Subcellular Localization of the Multidrug Resistance Proteins MRP1 and MRP2 J. Biol. Chem., June 13, 2003; 278(25): 22908 - 22917. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Grzywacz, J.-M. Yang, and W. N. Hait Effect of the Multidrug Resistance Protein on the Transport of the Antiandrogen Flutamide Cancer Res., May 15, 2003; 63(10): 2492 - 2498. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Leslie, R. J. Bowers, R. G. Deeley, and S. P. C. Cole Structural Requirements for Functional Interaction of Glutathione Tripeptide Analogs with the Human Multidrug Resistance Protein 1 (MRP1) J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 643 - 653. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Manciu, X.-B. Chang, F. Buyse, Y.-X. Hou, A. Gustot, J. R. Riordan, and J. M. Ruysschaert Intermediate Structural States Involved in MRP1-mediated Drug Transport. ROLE OF GLUTATHIONE J. Biol. Chem., January 24, 2003; 278(5): 3347 - 3356. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Leslie, R. G. Deeley, and S. P. C. Cole Bioflavonoid Stimulation of Glutathione Transport by the 190-kDa Multidrug Resistance Protein 1 (MRP1) Drug Metab. Dispos., January 1, 2003; 31(1): 11 - 15. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. P. Lin, D. R. Johnson, R. A. Finch, M. G. Belinsky, G. D. Kruh, and A. C. Sartorelli Comparative Study of the Importance of Multidrug Resistance-associated Protein 1 and P-Glycoprotein to Drug Sensitivity in Immortalized Mouse Embryonic Fibroblasts Mol. Cancer Ther., October 1, 2002; 1(12): 1105 - 1114. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. M. Fernandez, Z. Hollo, A. Kern, E. Bakos, P. A. Fischer, P. Borst, and R. Evers Role of the N-terminal Transmembrane Region of the Multidrug Resistance Protein MRP2 in Routing to the Apical Membrane in MDCKII Cells J. Biol. Chem., August 16, 2002; 277(34): 31048 - 31055. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Mao, W. Qiu, K. E. Weigl, P. A. Lander, L. B. Tabas, R. L. Shepard, A. H. Dantzig, R. G. Deeley, and S. P. C. Cole GSH-dependent Photolabeling of Multidrug Resistance Protein MRP1 (ABCC1) by [125I]LY475776. EVIDENCE OF A MAJOR BINDING SITE IN THE COOH-PROXIMAL MEMBRANE SPANNING DOMAIN J. Biol. Chem., August 2, 2002; 277(32): 28690 - 28699. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lee, S. Dallas, M. Hong, and R. Bendayan Drug Transporters in the Central Nervous System: Brain Barriers and Brain Parenchyma Considerations Pharmacol. Rev., December 1, 2001; 53(4): 569 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Zelcer, T. Saeki, G. Reid, J. H. Beijnen, and P. Borst Characterization of Drug Transport by the Human Multidrug Resistance Protein 3 (ABCC3) J. Biol. Chem., November 30, 2001; 276(49): 46400 - 46407. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. DeCory, K. M. Piech-Dumas, S.-S. Sheu, H. J. Federoff, and M. W. Anders Efflux of Glutathione Conjugate of Monochlorobimane from Striatal and Cortical Neurons Drug Metab. Dispos., October 1, 2001; 29(10): 1256 - 1262. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu, H. Chen, D. S. Miller, J. E. Saavedra, L. K. Keefer, D. R. Johnson, C. D. Klaassen, and M. P. Waalkes Overexpression of Glutathione S-Transferase II and Multidrug Resistance Transport Proteins Is Associated with Acquired Tolerance to Inorganic Arsenic Mol. Pharmacol., August 1, 2001; 60(2): 302 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gao, J. R. Broughman, T. Iwamoto, J. M. Tomich, C. J. Venglarik, and H. J. Forman Synthetic chloride channel restores glutathione secretion in cystic fibrosis airway epithelia Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L24 - L30. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Diah, P. K. Smitherman, J. Aldridge, E. L. Volk, E. Schneider, A. J. Townsend, and C. S. Morrow Resistance to Mitoxantrone in Multidrug-resistant MCF7 Breast Cancer Cells: Evaluation of Mitoxantrone Transport and the Role of Multidrug Resistance Protein Family Proteins Cancer Res., July 1, 2001; 61(14): 5461 - 5467. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Stephens, C. A. O'Neill, A. Warhurst, G. L. Carlson, M. Rowland, and G. Warhurst Kinetic Profiling of P-glycoprotein-Mediated Drug Efflux in Rat and Human Intestinal Epithelia J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 584 - 591. [Abstract] [Full Text] |
||||
![]() |
D. R. Johnson, R. A. Finch, Z. P. Lin, C. J. Zeiss, and A. C. Sartorelli The Pharmacological Phenotype of Combined Multidrug-Resistance mdr1a/1b- and mrp1-deficient Mice Cancer Res., February 1, 2001; 61(4): 1469 - 1476. [Abstract] [Full Text] |
||||
![]() |
H. Zeng, G. Liu, P. A. Rea, and G. D. Kruh Transport of Amphipathic Anions by Human Multidrug Resistance Protein 3 Cancer Res., September 1, 2000; 60(17): 4779 - 4784. [Abstract] [Full Text] |
||||
![]() |
P. Borst, R. Evers, M. Kool, and J. Wijnholds A Family of Drug Transporters: the Multidrug Resistance-Associated Proteins J Natl Cancer Inst, August 16, 2000; 92(16): 1295 - 1302. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O'Brien, G. D. Kruh, and K. D. Tew The Influence of Coordinate Overexpression of Glutathione Phase II Detoxification Gene Products on Drug Resistance J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 480 - 487. [Abstract] [Full Text] |
||||
![]() |
J. F. Rebbeor, G. C. Connolly, J. H. Henson, J. L. Boyer, and N. Ballatori ATP-dependent GSH and glutathione S-conjugate transport in skate liver: role of an Mrp functional homologue Am J Physiol Gastrointest Liver Physiol, August 1, 2000; 279(2): G417 - G425. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bourbouloux, P. Shahi, A. Chakladar, S. Delrot, and A. K. Bachhawat Hgt1p, a High Affinity Glutathione Transporter from the Yeast Saccharomyces cerevisiae J. Biol. Chem., April 28, 2000; 275(18): 13259 - 13265. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Jarvinen, P. Pietarinen-Runtti, K. Linnainmaa, K. O. Raivio, C. M. Krejsa, T. Kavanagh, and V. L. Kinnula Antioxidant defense mechanisms of human mesothelioma and lung adenocarcinoma cells Am J Physiol Lung Cell Mol Physiol, April 1, 2000; 278(4): L696 - L702. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Brangi, T. Litman, M. Ciotti, K. Nishiyama, G. Kohlhagen, C. Takimoto, R. Robey, Y. Pommier, T. Fojo, and S. E. Bates Camptothecin Resistance: Role of the ATP-binding Cassette (ABC), Mitoxantrone-resistance Half-Transporter (MXR), and Potential for Glucuronidation in MXR-expressing Cells Cancer Res., December 1, 1999; 59(23): 5938 - 5946. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zeng, L. J. Bain, M. G. Belinsky, and G. D. Kruh Expression of Multidrug Resistance Protein-3 (Multispecific Organic Anion Transporter-D) in Human Embryonic Kidney 293 Cells Confers Resistance to Anticancer Agents Cancer Res., December 1, 1999; 59(23): 5964 - 5967. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. M. H. Van Aubel, J. B. Koenderink, J. G. P. Peters, C. H. Van Os, and F. G. M. Russel Mechanisms and Interaction of Vinblastine and Reduced Glutathione Transport in Membrane Vesicles by the Rabbit Multidrug Resistance Protein Mrp2 Expressed in Insect Cells Mol. Pharmacol., October 1, 1999; 56(4): 714 - 719. [Abstract] [Full Text] |
||||
![]() |
Y. Jing, J. Dai, R. M.E. Chalmers-Redman, W. G. Tatton, and S. Waxman Arsenic Trioxide Selectively Induces Acute Promyelocytic Leukemia Cell Apoptosis Via a Hydrogen Peroxide-Dependent Pathway Blood, September 15, 1999; 94(6): 2102 - 2111. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kool, M. van der Linden, M. de Haas, G. L. Scheffer, J. M. L. de Vree, A. J. Smith, G. Jansen, G. J. Peters, N. Ponne, R. J. Scheper, et al. MRP3, an organic anion transporter able to transport anti-cancer drugs PNAS, June 8, 1999; 96(12): 6914 - 6919. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Roelofsen, G. Hooiveld, H Koning, R Havinga, P. Jansen, and M Muller Glutathione S-conjugate transport in hepatocytes entering the cell cycle is preserved by a switch in expression from the apical MRP2 to the basolateral MRP1 transporting protein J. Cell Sci., January 5, 1999; 112(9): 1395 - 1404. [Abstract] [PDF] |
||||
![]() |
R. Raggers, A van Helvoort, R Evers, and G van Meer The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane J. Cell Sci., January 2, 1999; 112(3): 415 - 422. [Abstract] [PDF] |
||||
![]() |
J. Dai, R. S. Weinberg, S. Waxman, and Y. Jing Malignant Cells Can Be Sensitized to Undergo Growth Inhibition and Apoptosis by Arsenic Trioxide Through Modulation of the Glutathione Redox System Blood, January 1, 1999; 93(1): 268 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Rebbeor, G. C. Connolly, M. E. Dumont, and N. Ballatori ATP-dependent Transport of Reduced Glutathione on YCF1, the Yeast Orthologue of Mammalian Multidrug Resistance Associated Proteins J. Biol. Chem., December 11, 1998; 273(50): 33449 - 33454. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bakos, R. Evers, G. Szakacs, G. E. Tusnady, E. Welker, K. Szabo, M. de Haas, L. van Deemter, P. Borst, A. Varadi, et al. Functional Multidrug Resistance Protein (MRP1) Lacking the N-terminal Transmembrane Domain J. Biol. Chem., November 27, 1998; 273(48): 32167 - 32175. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nagata, M. Nishitani, M. Matsuo, N. Kioka, T. Amachi, and K. Ueda Nonequivalent Nucleotide Trapping in the Two Nucleotide Binding Folds of the Human Multidrug Resistance Protein MRP1 J. Biol. Chem., June 2, 2000; 275(23): 17626 - 17630. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-M. Qian, W.-C. Song, H. Cui, S. P. C. Cole, and R. G. Deeley Glutathione Stimulates Sulfated Estrogen Transport by Multidrug Resistance Protein 1 J. Biol. Chem., February 23, 2001; 276(9): 6404 - 6411. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Liu, R. Sanchez-Fernandez, Z.-S. Li, and P. A. Rea Enhanced Multispecificity of Arabidopsis Vacuolar Multidrug Resistance-associated Protein-type ATP-binding Cassette Transporter, AtMRP2 J. Biol. Chem., March 16, 2001; 276(12): 8648 - 8656. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Daoud, M. Julien, P. Gros, and E. Georges Major Photoaffinity Drug Binding Sites in Multidrug Resistance Protein 1 (MRP1) Are within Transmembrane Domains 10-11 and 16-17 J. Biol. Chem., April 6, 2001; 276(15): 12324 - 12330. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wijnholds, C. A. A. M. Mol, L. van Deemter, M. de Haas, G. L. Scheffer, F. Baas, J. H. Beijnen, R. J. Scheper, S. Hatse, E. De Clercq, et al. Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs PNAS, June 20, 2000; 97(13): 7476 - 7481. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |